🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase II open-label study evaluating the pharmacokinetics and pha...
Status
Withdrawn
Location
St. Boniface General Hospital Research Centre
Start Date
2020-01
Trial ID
NCT04025177
Treatments Being Tested
This study with ALTB-268 will determine the safety, tolerability, pharmacok...
Status
Active Not Recruiting
Location
Syneos Health Clinical Research Services, LLC
Start Date
2025-11-17
Trial ID
NCT07350577
This study will investigate the pharmacokinetics, safety, and tolerability ...
Status
Completed
Location
Orlando Clinical Research Center
Start Date
2023-10-17
Trial ID
NCT06084104
This is a Phase 1, open-label, randomized, PK and safety study in a maximum...
Status
Completed
Location
Hammersmith Medicines Research
Start Date
2018-11-26
Trial ID
NCT03691584
Treatments Being Tested
The primary objective is to determine the safety and tolerability of SH3809...
Status
Unknown
Location
Shanghai Chest Hospital
Start Date
2021-04-02
Trial ID
NCT04843033
Treatments Being Tested
A Phase 1, First-In-Human, Randomized, Double-Blind, Placebo-Controlled Mul...
Status
Completed
Location
Nucleus Network Pty Ltd
Start Date
2025-05-29
Trial ID
NCT06981299
Treatments Being Tested
This is a multicenter, open-label, Phase 1b/2 efficacy and safety study of ...
Status
Terminated
Location
Uniwersyteckie Centrum Kliniczne Klinika Onkoligii i Radioterapii
Start Date
2022-12-07
Trial ID
NCT04915404
Treatments Being Tested
The purpose of the present study is to investigate the efficacy of 5% propo...
Status
Completed
Location
fayoum University
Start Date
2024-10-10
Trial ID
NCT06778655
Treatments Being Tested
This is a multicenter, safety and pharmacokinetic trial to determine the MT...
Status
Completed
Location
Children's Hospital Los Angeles
Start Date
2014-04-29
Trial ID
NCT01748149
Treatments Being Tested
The purpose of this study is to test a new drug called MK-2206. This study ...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
2010-07
Trial ID
NCT01169649
Treatments Being Tested